[Federal Register Volume 87, Number 49 (Monday, March 14, 2022)]
[Notices]
[Pages 14266-14267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05300]



[[Page 14266]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-22DF; Docket No. CDC-2022-0034]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies to take this opportunity to comment on a proposed and/
or continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Assessing the Availability of 
COVID-19 Testing at U.S. Airports. This project is designed to collect 
information on the availability of testing for COVID-19 to travelers at 
U.S. airports.

DATES: Written comments must be received on or before May 13, 2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0034, by either of the following methods:
     Federal eRulemaking Portal: regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed 
above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeff Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:

    (1) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information shall have practical utility;
    (2) Evaluate the accuracy of the agency's estimate of the burden 
of the proposed collection of information;
    (3) Enhance the quality, utility, and clarity of the information 
to be collected;
    (4) Minimize the burden of the collection of information on 
respondents, including through the use of automated collection 
techniques or other forms of information technology (e.g., 
permitting electronic submissions of responses); and
    (5) Assess information collection costs.

Proposed Project

    Information Collection for Assessing the Availability of COVID-19 
Testing at U.S. Airports--New--National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention's (CDC), National 
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division 
of Global Migration and Quarantine (DGMQ), Quarantine and Border Health 
Services Branch (QBHSB) requests approval for a new information 
collection request. This project pertains to collecting information on 
the availability of testing for COVID-19 to travelers at U.S. airports.
    The respondents are airport directors or their designees at 522 
airports in the continental United States, the District of Columbia, or 
any territory or possession of the United States. These airports serve 
passenger-carrying operations conducted on certified air carriers. This 
project will initially pilot with a sample of 100 airports and 
subsequently expand to include the remaining 422 Schedule A passenger-
carrying U.S. or territorial airports following the initial rollout, 
for a total of 522 airports. The 100 sampled airports were selected 
based on the following criteria: (1) Having more than 1,000 
international arrivals in 2019, or (2) having a CDC quarantine station, 
or if not meeting one of the above criteria, and (3) ranking among the 
top in domestic arrival passenger volume for 2019 (U.S. Bureau of 
Transportation). These airports represent 89% of domestic and 
international travel for 2019.
    To achieve DGMQ's mission, QBHSB works with domestic and 
international programs to protect the U.S. public by preventing 
importation of infectious disease through travel. Some U.S. airports 
have facilitated COVID-19 testing locations for departing or arriving 
domestic and international travelers (passengers and crew). QBHSB seeks 
to regularly obtain comprehensive and updated information on COVID-19 
testing activities occurring at U.S. airports, which allows CDC to 
monitor trends in testing offered at airports. The information 
collected in this project will be used primarily to ascertain the scope 
of testing activities and to eventually provide information to the 
traveling public on testing availability at U.S. airports. Existing 
surveillance systems do not collect this type of information, thereby 
preventing CDC from monitoring airport testing trends and improving 
program effectiveness, particularly during an emergency response.
    Currently, CDC is requesting this data be sent by airport directors 
or their designees at least twice per year, with monthly reminder 
emails being sent to encourage response. The consequences of reducing 
this frequency would be the inability to obtain comprehensive and 
updated information in a timely manner which could affect program 
improvement.
    CDC requests OMB approval for an estimated 33,060 annual burden 
hours. There is no cost to the respondents other than their time.

[[Page 14267]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Airport directors or managers   COVID-19 Airport             522              20          190/60          33,060
 (All airports).                 Testing Planner
                                 web form.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-05300 Filed 3-11-22; 8:45 am]
BILLING CODE 4163-18-P